APS and NPS treatments significantly reduced the expression of IL-6, IL-8, and MCP-1 at hour 12 after poly(I:C) stimulation, while the both treatments enhanced the levels of TNF-α mRNA at hour 3 (Figure 3). The gene discussed is IL6; the disease is autoimmune polyendocrinopathy.